BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6861924)

  • 1. Tuberculosis emerging in patients treated with corticosteroids.
    Haanaes OC; Bergmann A
    Eur J Respir Dis; 1983 May; 64(4):294-7. PubMed ID: 6861924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risks of infection or reactivation of tuberculosis associated with chronic corticosteroid therapy.
    Cline JC; Davis SM
    Ann Pharmacother; 1997 Jun; 31(6):775-6. PubMed ID: 9184722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Corticosteroids as adjuvants in the treatment of tuberculosis].
    Senderovitz T; Viskum K
    Ugeskr Laeger; 1994 Sep; 156(37):5268-72. PubMed ID: 7941062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corticosteroids and the risk of atrial fibrillation.
    van der Hooft CS; Heeringa J; Brusselle GG; Hofman A; Witteman JC; Kingma JH; Sturkenboom MC; Stricker BH
    Arch Intern Med; 2006 May; 166(9):1016-20. PubMed ID: 16682576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Preventive measures against tuberculosis in working facilities and companies].
    Suzuki K; Satou K
    Kekkaku; 2007 Mar; 82(3):201-16. PubMed ID: 17444125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A clinical study in the collagen disease patients developed pulmonary tuberculosis during corticosteroid administration].
    Sasaki Y; Yamagishi F; Yagi T; Yamatani H; Kuroda F; Shoda H
    Kekkaku; 2000 Oct; 75(10):569-73. PubMed ID: 11109770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study on clinico-pathological features of active pulmonary tuberculosis found at autopsy in a general hospital].
    Yamamoto A; Tsuchiya K; Kusajima K; Shimoide H; Nunomura M; Hebisawa A
    Kekkaku; 2009 Feb; 84(2):71-8. PubMed ID: 19280911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of non-tuberculous pulmonary mycobacteriosis].
    Sakatani M; Nakajima Y
    Kekkaku; 2006 Jan; 81(1):35-50. PubMed ID: 16479999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuberculosis in the head and neck: experience in India.
    Prasad KC; Sreedharan S; Chakravarthy Y; Prasad SC
    J Laryngol Otol; 2007 Oct; 121(10):979-85. PubMed ID: 17367564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pulmonary tuberculosis in the compromised host at the point of clinical view].
    Yamagishi F; Sasaki Y; Suzuki K
    Kekkaku; 1993 Sep; 68(9):605-10. PubMed ID: 8230964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corticosteroid use in rheumatoid arthritis: prevalence, predictors, correlates, and outcomes.
    Caplan L; Wolfe F; Russell AS; Michaud K
    J Rheumatol; 2007 Apr; 34(4):696-705. PubMed ID: 17299838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of corticosteroid induced osteoporosis in inpatients recently discharged from a tertiary teaching hospital.
    Smith MD; Cheah SP; Taylor K; Ahern MJ
    J Rheumatol; 2001 Mar; 28(3):566-70. PubMed ID: 11296960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of tuberculosis among patients receiving treatment with oral corticosteroids.
    Agrawal PN; Gupta D; Aggarwal AN; Behera D
    J Assoc Physicians India; 2000 Sep; 48(9):881-4. PubMed ID: 11198786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of post-operative topical corticosteroids in recurrence rate after pterygium excision with conjunctival autograft.
    Yaisawang S; Piyapattanakorn P
    J Med Assoc Thai; 2003 Jun; 86 Suppl 2():S215-23. PubMed ID: 12929992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of corticosteroids for the treatment of severe and fulminant forms of autoimmune hepatitis.
    Ichai P; Duclos-Vallée JC; Guettier C; Hamida SB; Antonini T; Delvart V; Saliba F; Azoulay D; Castaing D; Samuel D
    Liver Transpl; 2007 Jul; 13(7):996-1003. PubMed ID: 17370335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attained adult height in juvenile rheumatoid arthritis with or without corticosteroid treatment.
    Wang SJ; Yang YH; Lin YT; Yang CM; Chiang BL
    Clin Rheumatol; 2002 Sep; 21(5):363-8. PubMed ID: 12223982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental study on the use of intravenous immunoglobulin (IVIg) in patients with steroid-resistant Crohn's disease.
    Chrissafidou A; Malek M; Musch E
    Z Gastroenterol; 2007 Jul; 45(7):605-8. PubMed ID: 17620224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination therapy of intravenous immunoglobulin and corticosteroid in the treatment of toxic epidermal necrolysis and Stevens-Johnson syndrome: a retrospective comparative study in China.
    Yang Y; Xu J; Li F; Zhu X
    Int J Dermatol; 2009 Oct; 48(10):1122-8. PubMed ID: 19775409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.